Monoclonal antibody 2C6 targets cross-clade conformational epitope in GP41 with highly active antibody dependent cell cytotoxicity
SOJAR, ET AL. 2019. J VIROL, DOI:10.1128/JVI.00772-19
RESOURCES
Where research scientists come to find up to date resources on antibody discovery against challenging membrane protein targets.
Category: Virology
Convalescent patient-derived monoclonal antibodies targeting different epitopes of E protein confer protection against Zika virus in a neonatal mouse model
NIU, ET AL. 2019. EMERG MICROBES INFECT 8(1):749-759
Early human B cell response to Ebola virus in four U.S. survivors of infection
WILLIAMSON, ET AL. 2019. J VIROL, DOI:10.1128/JVI.01439-18
Optimal therapeutic activity of monoclonal antibodies against chikungunya virus requires Fc-FcγR interaction on monocytes
FOX, ET AL. 2019. SCI IMMUNOL, 4(32): EAAV5062
Structural basis of a potent human monoclonal antibody against Zika virus targeting a quaternary epitope
LONG, ET AL. 2019. PNAS DOI: 10.1073/PNAS.1815432116.
Increased breadth of HIV-1 neutralization achieved by diverse antibody clones each with limited neutralization breadth
CHUKWUMA, ET AL. 2018. PLOS ONE 13(12), E0209437.
Broadly neutralizing antibody mediated clearance of human hepatitis C virus infection
KINCHEN, ET AL. 2018. CELL HOST MICROBE 24:717-730.
In vivo delivery of synthetic human DNA-encoded monoclonal antibodies protect against ebolavirus infection in a mouse model
PATEL, ET AL. 2018. CELL REPORTS 25:1982-1993.
Systematic analysis of monoclonal antibodies against Ebola virus GP defines features that contribute to protection
SAPHIRE, ET AL. 2018. CELL 174(4):938-952
